The study for simeprevir, peg-interferon, and ribavirin treatment efficacy against the patients with chronic hepatitis C (Multicenter trial)
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000017654
- Lead Sponsor
- Shinanomachi Liver Conference
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who were thought to be unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sustained virological response rate
- Secondary Outcome Measures
Name Time Method peg-interferon alfa-2a or alfa-2b